Save the Date: American cancer society corporate impact conference - June 9-10, 2011
Cancer touches more than 40 percent of Americans in their lifetime. With a total cost of nearly $264 billion in health care expenses and lost productivity in 2010, the disease has a major impact on the workforce. If you are responsible for your company's overall health management, health and wellness programs, corporate philanthropy, and/or community involvement initiatives, you can help change the course of cancer in your company and community by joining us for the 2011 American Cancer Society Corporate Impact Conference.
WHEN: Thursday and Friday, June 9-10, 2011
WHERE: Radisson Plaza Hotel - Minneapolis, Minn.
What can you expect?
Unlike many general health and wellness conferences created for corporations, the 2011 Corporate Impact Conference, co-hosted by the Minnesota CEOs Against Cancer® Chapter, will focus on cancer and the research supporting corporate intervention to help save lives from the disease. By attending this conference, you will learn how to bolster your bottom line with reduced absenteeism and health care costs, while increasing employee morale and engagement in the fight against cancer. The National Meeting of the CEOs Against Cancer, which is part of the 2011 Corporate Impact Conference, will focus on shaping the future of health care in the workplace.
The conference will be presented by the American Cancer Society Corporate & Systems Initiative - an effort which creates meaningful, long-term relationships with corporations and employers of all sizes by engaging them in delivery of the Society's lifesaving mission and support for its numerous programs and services. The Corporate & Systems Initiative helps companies implement scientifically-sound, comprehensive health and wellness programs and provides information and high-quality support for cancer screening and care to help people stay well and get well.
For more information and updates on the 2011 American Cancer Society Corporate Impact Conference, stay connected by visiting acsworkplacesolutions.com/impact-overview.asp.
-
Most popular related searches
Related news
-
New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies
Thermo Fisher Scientific today announced the launch of Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, a GMP-manufactured cell culture medium that supports large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells. This is the first medium from Thermo Fisher specifically designed to support expansion of NK cells for cell therapy applications and is supported by raw material traceability and regulatory documentation. "Cell therapy developers are increasingly...
-
Creative BioMart Provides a Wide Range of Centromere Proteins for Research Use
Creative BioMart, a world leading biotech company specialized in providing quality protein products and services to customers all over the world now provides a wide selection of centromere proteins for cancer research. Centromeres are specialized DNA sequences in chromosomes, which hold two daughter chromatids together. Centromeres represent a contractile region of the chromosome in which two identical sister chromatids are most in contact. The centromere is the attachment point of the kinetochore, a highly...
-
Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology
To support clinical research needs using next-generation sequencing (NGS), Thermo Fisher Scientific today announced it is accepting new submissions for its Oncomine Clinical Research Grant. The latest call for proposals aims to provide funding for clinical research programs that leverage NGS in solid tumors and hematology-oncology applications. The Oncomine Clinical Research Grant awards independent clinical research proposals with up to $200,000 in reagents and general funding. Applications are reviewed for...
-
Exosome Targeting Services at Creative Biolabs Ready to Boost Drug Delivery Research
Exosomes are picking up steam among scientists because they can perform a role in the immune response, antigen presentation, cell migration, cell differentiation, and tumor invasion. Exosomes, which provide a mechanism for macromolecules to be exchanged between cells, play a part in the development of various illnesses, particularly in the modulation of the cancer microenvironment and immune response. Recently, several studies have shown that exosomes express some lipids and cell adhesion molecules and ligands...
-
Second Genome Announces Milestone Accomplished in Collaboration with Bayer, Demonstrating Broad Application of Company`s Machine Learning Platform to Identify Novel Proteins for the Development of Next-Generation Insect-Control Solutions
Second Genome, a biotechnology company that leverages its proprietary platform sg-4sight to discover and develop precision therapies and biomarkers from public and proprietary microbiome data, today announced it has achieved a milestone in its multi-year collaboration with Bayer to discover proteins for potential development of next-generation insect-control products. “We are pleased to demonstrate successful execution of our collaboration with Bayer and the versatile application of our sg-4sight discovery...
Customer comments
No comments were found for Save the Date: American cancer society corporate impact conference - June 9-10, 2011. Be the first to comment!